Test Code CHOL 
Methodology Colorimetric 
Description Useful for evaluation of cardiovascular risk, suggestion of cholestatic liver disease, and evidence for abetalipoproteinemia.

NOTE: Acetaminophen concentrations at toxic levels and high doses of N-Acetylcysteine (NAC) used to treat acetaminophen intoxication can falsely lower the result of this test.
N-Acetylcysteine used as mucolytic will not influence the result of this test.

NOTE: This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policy "Lipids Testing". Please verify that the diagnosis code (ICD-9) you have chosen demonstrates medical necessity for the test as documented in the physician's patient record. The CMS web site or the NorDx Limited Coverage Documentation Guide are available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD-9 code chosen. 

Specimen Draw blood in either a plain, red-top tube or serum gel tube. Spin down and send 1.0 mL (minimum volume: 0.3 mL) of serum refrigerated. (GROSSLY HEMOLYZED SPECIMEN WILL BE REJECTED.) 
MMC Specimen Draw blood in a plasma gel tube. 1.0 mL (0.3 mL minimum) of plasma required. (GROSSLY HEMOLYZED SPECIMEN WILL BE REJECTED.) 
Reference Values 112 - 199 mg/dL 
Analytic Time 1 Day 
Day(s) Test Set Up Monday through Sunday 
CPT Code(s) 82465